广告
加载中

京东健康上半年营收409亿 增长主要由医药和健康产品收入驱动

亿邦动力 2026-08-14 11:12
亿邦动力 2026/08/14 11:12

邦小白快读

EN
全文速览

这篇文章核心公布了京东健康2026年上半年的中期业绩,以及最新业务进展,核心干货如下:

1. 核心业绩数据:上半年京东健康总收入408.88亿元,同比增长15.9%;毛利106.86亿元,增长20.2%;经营盈利31.74亿元,增长49.2%;非国际财务报告准则下经营盈利34.83亿元,增长40.3%,经营盈利率从7.0%提升到8.5%,整体盈利增长远超营收增速,表现亮眼。

2. 增长来源:本次增长主要由医药和健康产品收入驱动,该板块收入从去年同期293亿元增至339亿元,同比增15.6%,增长动力来自活跃用户增加、用户额外购买、线上渗透率提升、产品品类丰富。

3. 业务新进展:当前京东健康正在多业务协同推进AI全场景落地,覆盖互联网医疗、线下服务、智慧医疗多个领域。

本文披露了大健康线上行业的最新发展动向,能为大健康品牌商提供战略参考,干货内容如下:

1. 消费与渠道趋势:当前医药健康产品线上渗透率仍在提升,线上渠道依然保持两位数增长,京东健康平台该板块收入上半年达339亿元,同比增15.6%,品牌商布局线上渠道仍有充足增量空间。

2. 用户特征变化:增长来自活跃用户数量增加以及用户额外购买,说明用户线上购买健康产品的习惯已经养成,单用户价值仍有提升空间,品牌商可通过用户精细化运营挖掘增长。

3. 行业新方向:AI已经在大健康全场景落地,覆盖专病诊疗辅助、健康管理等多个领域,品牌商可结合AI能力升级产品与服务,对接头部平台AI生态拓展业务边界。

本文为大健康品类线上卖家提供了市场动向与机会参考,核心干货如下:

1. 市场整体情况:当前大健康线上赛道仍保持较快增长,京东健康整体营收增15.9%,盈利增速接近50%,赛道整体盈利能力持续提升,是仍有增量的增长市场,入场与拓展机会充足。

2. 可挖掘的增长机会:行业增长核心驱动因素包括活跃用户增长、用户购买频次和客单价提升、线上渗透率提升、品类丰富,卖家可通过拓展细分品类、深耕用户运营来挖掘增量空间。

3. 平台生态红利:京东健康当前正在拓展AI全场景服务,同时布局线下综合门诊,平台生态不断完善,能为卖家提供流量与服务支撑,卖家可依托平台新业务获得更多曝光与转化机会。

本文为健康产品生产工厂披露了行业需求与转型方向,核心干货如下:

1. 整体商业机会:当前医药健康产品线上需求仍保持15%以上的增速,线上渗透率持续提升,线上市场增量空间充足,工厂可加大适配线上消费需求的产品生产,拓展线上渠道抓住增长红利。

2. 产品开发方向:京东健康平台收入增长受益于品类丰富,说明多元化细分健康产品仍有市场机会,工厂可针对线上用户的消费习惯,开发更多细分品类的健康产品,匹配线上消费需求。

3. 数字化转型启示:当前大健康行业已经全面推进AI数字化落地,工厂可借力头部平台的数字化能力,推进自身生产、销售环节的数字化升级,加强和京东健康这类头部平台的合作,提升自身市场竞争力。

本文为大健康领域服务商披露了行业趋势与客户需求方向,核心干货如下:

1. 行业发展趋势:当前大健康线上赛道处于稳定上升期,头部平台京东健康上半年营收增15.9%,盈利增速达到49.2%,远高于营收增速,赛道整体盈利性持续向好,市场空间充足,处于上升发展阶段。

2. 核心客户需求:头部平台已经开始推进AI全场景落地,覆盖互联网医疗辅助诊疗、线下健康服务、AI健康管理、医院临床服务等多个场景,AI赋能大健康已经成为明确的行业方向,AI技术服务商、医疗服务服务商都有大量需求空间。

3. 业务开发方向:当前行业需要针对不同场景的AI解决方案,包括专病AI模型、AI长期健康管理、临床药事管理等,服务商可围绕这些细分场景开发针对性方案,对接头部平台与医疗机构需求。

本文展示了头部健康互联网平台京东健康的最新发展动向,可供同类平台商参考,核心干货如下:

1. 平台最新运营布局:京东健康目前推进多业务协同的AI全场景落地,互联网医疗领域联合头部三甲医院共建专病AI模型,推出“京东知医”接入互联网医院辅助诊疗;智慧医疗升级AI医生“大为”功能,落地“京东卓医”覆盖医院临床服务,同时拓展线下“体检+口腔+医美”综合门诊,走线上线下协同路线。

2. 增长路径参考:平台可依托医药健康商品零售的基本盘,抓住线上渗透率提升的行业红利,通过丰富品类、拉新提升单用户价值实现增长,同时拓展医疗服务板块拉动盈利提升。

3. 方向参考:AI+医疗是明确的发展风向,平台可提前布局AI场景落地,结合线下服务拓展边界,提升平台整体竞争力,同时发挥零售基本盘的优势支撑创新业务发展。

本文为互联网健康产业研究者提供了头部企业最新发展数据与产业动向,核心干货如下:

1. 产业最新盈利数据:头部平台京东健康2026年上半年营收408.88亿元,同比增15.9%,经营盈利同比增49.2%,经营盈利率提升1.5个百分点,说明互联网健康产业已经进入盈利兑现期,主流商业模式已经跑通,盈利性持续提升。

2. 产业最新动向:当前头部平台已经进入AI全场景商业化落地阶段,AI已经应用在辅助诊疗、健康管理、临床服务等多个细分场景,618期间AI医生服务量同比增近4倍,说明AI+医疗已经从概念投入阶段进入商业化应用阶段。

3. 产业增长逻辑:当前产业增长仍然由医药健康产品零售线上化驱动,同时医疗服务板块逐步成熟,零售+医疗服务+AI赋能的多元化协同商业模式已经成型,为研究产业发展方向提供了典型样本。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article highlights JD Health's interim results for the first half of 2026 and its latest business updates, with key takeaways as follows:

1. Core financial performance: JD Health posted total revenue of 40.888 billion yuan in H1 2026, up 15.9% year-on-year. Gross profit reached 10.686 billion yuan, an increase of 20.2%. Operating profit hit 3.174 billion yuan, rising 49.2%, while adjusted operating profit under non-IFRS stood at 3.483 billion yuan, up 40.3% year-on-year. Its operating margin increased from 7.0% to 8.5%, with profit growth far outpacing revenue growth, delivering a strong performance.

2. Growth drivers: The overall growth was primarily led by revenue from pharmaceuticals and health products, which climbed from 29.3 billion yuan in the same period last year to 33.9 billion yuan, a 15.6% year-on-year increase. This growth was fueled by a growing active user base, incremental purchases from existing users, rising online penetration, and expanded product categories.

3. New business developments: JD Health is currently rolling out AI across all business scenarios in a coordinated multi-business strategy, covering Internet medical care, offline services, and smart healthcare.

This article outlines the latest trends in the online big health industry, providing strategic insights for big health brands, with key takeaways as follows:

1. Consumption and channel trends: Online penetration of pharmaceutical and health products continues to rise, and the online channel still maintains double-digit growth. JD Health’s revenue from this segment reached 33.9 billion yuan in H1 2026, up 15.6% year-on-year, indicating there is still substantial room for incremental growth for brands that expand their online channel布局.

2. Shifting user characteristics: Growth comes from a growing active user base and incremental spending per user, which shows consumers have formed the habit of purchasing health products online, and user lifetime value still has room to grow. Brands can unlock further growth through refined user operations.

3. New industry directions: AI has been deployed across all big health scenarios, covering specialized disease diagnosis assistance, health management and other fields. Brands can upgrade their products and services by integrating AI capabilities, and tap into broader business boundaries by connecting with the AI ecosystem of leading industry platforms.

This article offers insights into market trends and opportunities for online big health sellers, with key takeaways as follows:

1. Overall market conditions: The online big health sector still maintains relatively strong growth. JD Health’s overall revenue rose 15.9%, with profit growth approaching 50%, and the sector’s overall profitability continues to improve. This remains a growing market with abundant incremental opportunities for new entry and business expansion.

2. Untapped growth opportunities: Core industry growth drivers include growing active users, rising purchase frequency and average order value, increasing online penetration, and category expansion. Sellers can unlock incremental growth by expanding into niche categories and deepening user operations.

3. Platform ecosystem dividends: JD Health is currently expanding AI-powered full-scenario services and布局 offline comprehensive outpatient clinics, continuously improving its platform ecosystem to provide sellers with traffic and service support. Sellers can gain more exposure and conversion opportunities by leveraging the platform’s new business initiatives.

This article outlines industry demand and transformation directions for health product manufacturers, with key takeaways as follows:

1. Overall business opportunities: Online demand for pharmaceutical and health products still maintains growth of over 15%, with online penetration continuing to rise, leaving substantial incremental room in the online market. Manufacturers can increase production of products adapted to online consumer demand and expand online channels to capture growth dividends.

2. Product development direction: JD Health’s revenue growth has benefited from category expansion, indicating there is still market opportunity for diversified niche health products. Manufacturers can develop more segmented health products aligned with online consumer habits to match online demand.

3. Digital transformation insights: The big health industry is now fully advancing AI-powered digital adoption. Manufacturers can leverage the digital capabilities of leading platforms to upgrade digitalization in their production and sales processes, strengthen cooperation with leading platforms like JD Health, and improve their own market competitiveness.

This article covers industry trends and client demand directions for service providers in the big health sector, with key takeaways as follows:

1. Industry development trends: The online big health sector is currently in a period of steady growth. Leading platform JD Health posted 15.9% revenue growth in H1 2026, with operating profit growing 49.2%—far outpacing revenue growth. The sector’s overall profitability continues to improve, with ample market space and ongoing upward momentum.

2. Core client demand: Leading platforms have begun rolling out AI across all business scenarios, covering Internet medical assisted diagnosis and treatment, offline health services, AI-powered health management, hospital clinical services and other use cases. AI-enabled big health has become a clear industry direction, creating substantial demand for both AI technology service providers and medical service providers.

3. Business development direction: The industry currently needs tailored AI solutions for different scenarios, including specialized disease AI models, AI-powered long-term health management, and clinical pharmacy management. Service providers can develop targeted solutions for these segmented scenarios to meet the demand of leading platforms and medical institutions.

This article presents the latest developments of leading online health platform JD Health, offering a reference for peer platforms, with key takeaways as follows:

1. Latest platform operations and布局: JD Health is advancing coordinated full-scenario AI deployment across multiple businesses. In Internet healthcare, it has co-built specialized disease AI models with leading top-tier public hospitals, and launched "JD Zhi Yi" to provide assisted diagnosis support for connected Internet hospitals. For smart healthcare, it upgraded the functionality of its AI doctor "Da Wei" and launched "JD Zhuo Yi" to cover hospital clinical services. It is also expanding offline comprehensive outpatient clinics covering physical examinations, dentistry and medical aesthetics, pursuing an integrated online-offline growth strategy.

2. Growth path reference: Platforms can anchor their core retail business for pharmaceutical and health products, capture the industry dividend of rising online penetration, drive growth by expanding categories, acquiring new users and increasing per-user value, and boost profitability by expanding into medical services.

3. Strategic direction reference: AI plus healthcare is a clear industry trend. Platforms can proactively deploy AI across scenarios, expand business boundaries by integrating offline services, improve overall platform competitiveness, and leverage the advantages of their core retail business to support the development of innovative new businesses.

This article provides the latest operating data and industry trends from a leading industry player for researchers focused on the Internet health industry, with key takeaways as follows:

1. Latest industry profitability data: Leading platform JD Health posted H1 2026 revenue of 40.888 billion yuan, up 15.9% year-on-year, with operating profit growing 49.2% year-on-year, and operating margin increasing 1.5 percentage points. This demonstrates the Internet health industry has entered a phase of profit realization, its mainstream business models are proven viable, and profitability continues to improve.

2. Latest industry developments: Leading industry players have now entered the stage of commercial full-scenario deployment of AI, with AI already applied to assisted diagnosis, health management, clinical services and multiple other segmented scenarios. During the 2026 618 shopping festival, service volume from AI doctors grew nearly fourfold year-on-year, confirming that AI plus healthcare has moved from concept-driven investment to commercial application.

3. Industry growth logic: Industry growth is still primarily driven by the online penetration of pharmaceutical and health product retail, while the medical service segment is gradually maturing. A diversified coordinated business model combining retail, medical services and AI enabling has taken shape, providing a typical case study for research on the future direction of the industry.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

【亿邦原创】8月13日,京东健康(06618/86618)2026年中期业绩公告。2026年上半年,京东健康总收入为人民币408.88亿元,同比增长15.9%;毛利106.86亿元,同比增长20.2%;经营盈利31.74亿元,同比增长49.2%;期间盈利34.35亿元,同比增长32.6%;非国际财务报告准则指标下(Non-IFRS)经营盈利34.83亿元,同比增长40.3%,经营盈利率从7.0%提升至8.5%。

财报显示,该业务收入从去年同期的293亿元增至339亿元,同比增长15.6%。商品收入的增长驱动力主要有活跃用户数量增加及用户的额外购买、医药和健康产品销售的线上渗透率不断提高及产品品类的丰富。

报告期内,京东健康多业务协同推进AI全场景落地:互联网医疗领域,京东健康联合广医一院、北大肿瘤医院等共建呼吸、消化、肿瘤AI专病模型,并发布"京东知医"全面接入互联网医院辅助诊疗;线下服务与到家服务方面,北京首家"体检+口腔+医美"综合门诊开业;智慧医疗及数字健康方面,AI医生"大为"新增长期健康档案记忆,618期间服务量同比增近4倍;"京东卓医"落地多家医院,覆盖临床营养与药事管理。


文章来源:亿邦动力

广告
微信
朋友圈

FAQ回顾

京东健康2026年上半年经营情况怎么样?

2026年上半年京东健康总收入408.88亿元,同比增长15.9%;毛利106.86亿元,同比增长20.2%;经营盈利31.74亿元,同比增长49.2%;非IFRS下经营盈利34.83亿元,经营盈利率从7.0%提升至8.5%。

京东健康在AI医疗领域有哪些布局?

京东健康推进AI全场景落地:联合广医一院、北大肿瘤医院等共建呼吸、消化、肿瘤AI专病模型,发布"京东知医"接入辅助诊疗,AI医生"大为"新增长期健康档案记忆,618期间服务量同比增近4倍,"京东卓医"落地多家医院。

京东健康商品收入增长的驱动因素是什么?

京东健康商品收入增长主要有三个驱动力:一是活跃用户数量增加及用户额外购买,二是医药和健康产品销售的线上渗透率不断提高,三是平台健康相关产品品类持续丰富,2026年上半年商品收入达339亿元,同比增长15.6%。

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0